Department of Woman and Child Health, Fondazione Policlinico A. Gemelli, Università Cattolica del Sacro Cuore, Rome, Italy.
Int J Gynecol Cancer. 2018 Nov;28(9):1672-1675. doi: 10.1097/IGC.0000000000001363.
Ovarian cancer is commonly diagnosed at an advanced stage. Complete macroscopic eradication of the disease is associated with improved prognosis. In this setting, the surgical resection of enlarged cardiophrenic lymph nodes (CPLNs) can help to achieve cytoreduction to no gross residual disease. During surgery, CPLN removal is usually performed either via video-assisted thoracic surgery or through a large transdiaphragmatic or subxiphoid incision. In the present case, we propose the use of an intraoperative transdiaphragmatic ultrasound to confirm preoperative imaging and to obtain a precise localization of the suspicious CPLNs.
A 50-year-old woman without peritoneal carcinomatosis was diagnosed with bilateral ovarian cancer and enlarged inguinal, pelvic, aortic, and cardiophrenic nodes. She underwent primary debulking surgery, including radical hysterectomy, bilateral salpingo-oophorectomy, omentectomy, peritoneal biopsies, and bulky nodes resection, at the iliac, inguinal, and lumboaortic regions.
After obtaining complete abdominal cytoreduction, an intraoperative ultrasound scan was performed. Two enlarged CPLNs were ultrasonographically visualized using a convex contact probe through a transhepatic window, and their exact location was identified. After complete mobilization of the right liver, the right diaphragm was incised, proximal to the site of the lymphadenopathies. The 2 lymph nodes were identified, grasped, and removed by transdiaphragmatic approach. Absence of other residual disease was confirmed by thoracic inspection, palpation, and by a subsequent intraoperative ultrasound control. At final histology, CPLNs were positive for infiltration of high-grade serous ovarian carcinoma.
Intraoperative transdiaphragmatic ultrasound represents a possible approach to localize suspicious CPLNs and to guide their surgical eradication.
卵巢癌通常在晚期诊断。完全肉眼消除疾病与改善预后相关。在这种情况下,切除增大的心膈角淋巴结(CPLN)有助于实现无肉眼残留疾病的减瘤。在手术中,CPLN 的切除通常通过电视辅助胸腔镜手术或通过大的经膈肌或剑突下切口进行。在本病例中,我们建议在术中使用经膈肌超声来确认术前影像学并对可疑的 CPLN 进行精确定位。
一名 50 岁女性,无腹膜癌病,诊断为双侧卵巢癌和增大的腹股沟、骨盆、主动脉和心膈角淋巴结。她接受了原发性减瘤手术,包括根治性子宫切除术、双侧输卵管卵巢切除术、网膜切除术、腹膜活检术和大块淋巴结切除术,在髂、腹股沟和腰主动脉区域进行。
在获得完全的腹部减瘤后,进行了术中超声扫描。使用凸面接触探头通过经肝窗超声可见两个增大的 CPLN,并确定其确切位置。在完全游离右肝后,切开右膈肌,靠近淋巴结病变部位。通过经膈肌入路识别、抓住并切除了 2 个淋巴结。通过胸腔检查、触诊和随后的术中超声控制确认没有其他残留疾病。在最终的组织学检查中,CPLN 浸润了高级别浆液性卵巢癌。
术中经膈肌超声可能是一种定位可疑 CPLN 并指导其手术切除的方法。